Belnacasan is a drug developed by Vertex Pharmaceuticals which acts as a potent and selective inhibitor of the enzyme caspase 1. From Wikipedia
Preclinical mouse experiments demonstrate that belnacasan restores chemotherapy sensitivity, opening prospects for clinical evaluation in bladder and other cancers.
